Company Filing History:
1 out of 280 
1 out of 26 
1 out of 1 Years Active: 2013
Title: Innovations of Georges Moarbess in Cancer Treatment
Introduction
Georges Moarbess is a notable inventor based in Nord, France, recognized for his contributions to the field of cancer treatment. He holds a patent for a significant innovation that focuses on Imidazol[1,2-α]quinoxalines and their derivatives. This invention aims to provide new therapeutic options for cancer patients.
Latest Patents
Moarbess's patent, titled "Imidazo[1,2-a]quinoxaline compounds for the treatment of cancers," encompasses pharmaceutical compositions that include these compounds and their therapeutic uses. The compound is represented by a general formula, which highlights its potential in cancer therapy.
Career Highlights
Throughout his career, Georges Moarbess has worked with esteemed institutions such as the University of Montpellier and the American University of Beirut. His work in these academic environments has contributed to the advancement of research in cancer treatment.
Collaborations
Moarbess has collaborated with notable colleagues, including Carine Deleuze-Masquefa and Pierre-Antoine Bonnet. These partnerships have likely enriched his research and development efforts in the field of oncology.
Conclusion
Georges Moarbess's innovative work in developing Imidazol[1,2-α]quinoxalines represents a significant advancement in cancer treatment. His contributions continue to influence the medical field and offer hope for improved therapeutic options for patients.